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Nanomaterials and the 
Precautionary Principle
doi:10.1289/ehp.1103687
Kessler (2011) provided a valuable update on 
the current state of research and regulatory pol­
icy concerning nano  materials. However, the 
article could give the mis  leading impression 
that the precautionary principle constitutes a 
straightforward guideline for improving public 
policy in this area. Instead, the precautionary 
principle provides only a general framework 
that must be specified before one can ade­
quately assess its implications for policy.  
Near the beginning of the article, Kessler 
(2011) quoted Alexis Baden­Mayer, who 
worried, 
[I]n our regulation of food and consumer prod­
ucts, we don’t implement the precautionary 
principle. Things go to market before we know 
whether or not they’re really safe for human 
beings over the long term. 
Kessler (2011) concluded with a quotation 
from Michael Hansen: 
I think we need to take a precautionary approach 
because we’ve learned the hard way over and over 
and over again. You’d think we would learn.
By framing the issues in this way, Kessler 
(2011) intimated that the precautionary prin­
ciple could serve as a valuable guide for future 
research and policy making. However, with­
out further specification, the principle provides 
only a rough outlook or orientation rather than 
a specific regulatory plan of action; its merits 
cannot be clearly evaluated unless a number of 
further questions are answered.
A number of scholars have attempted to clar­
ify how various formulations of the precaution­
ary principle relate to one another. There are at 
least three important features that vary in differ­
ent accounts of the principle: a) the threats that 
ought to be addressed; b) the amount and kinds 
of knowledge necessary to justify precaution­
ary measures; and c) the specific precautionary 
measures that ought to be taken (Elliott 2010; 
Manson 2002; Sandin 1999). All three issues 
require further discussion in the case of nano­
material research and regulation.
Regarding threats, one of the most crucial 
issues is whether it is sufficient to show that 
nano  particles are safe for humans or whether 
they must also be shown to be safe for the 
environment—and, if so, what environmental 
impacts must be tested. Andrew Maynard 
hinted at this issue: 
I think there is a greater chance that we’re going 
to see long­term environmental impacts from 
these materials than we are going to see short­term 
  consumer impacts. (Kessler 2011) 
Given the vast array of nano  particles under 
consideration, it seems doubtful that they 
could all be thoroughly tested for a wide 
range of environmental effects before allow­
ing their use.
This raises the question of how much evi­
dence should be demanded before approving 
particular sorts of nano  particles. A number 
of questions are relevant here, some of which 
are touched on by Kessler (2011): What 
kinds of screening studies should be required? 
When should in vivo studies be required? 
What structural or functional changes to 
a nano  particle (e.g., size, crystal structure, 
manufacturing process) should trigger new 
toxicity studies? Should by­products of the 
production process also be studied in order to 
declare a nano  particle safe (Templeton et al. 
2006)? What steps must be taken to ensure 
that multiple manufacturing batches of the 
same nano  particle result in products with the 
same toxicity profile? Does it matter what 
kinds of consumer products the nano  particles 
are used for? 
Finally, although many proponents and 
opponents of the precautionary principle treat 
the precautionary principle as if it requires 
bans on potential threats until they are shown 
to be safe, a range of other positions are also 
available on this issue. Three options include 
a) insisting that government agencies be noti­
fied when products contain particular nano­
particles; b) demanding labeling; or c) taking 
steps to minimize human or environmen­
tal exposure to nano  particles until they have 
received further testing. Kessler (2011) high­
lighted our present failure to achieve some of 
these minimal steps.
These considerations do not by them­
selves count as sufficient reasons for reject­
ing the precautionary principle, but they do 
show that the decision to adopt it is the start 
of a complicated conversation rather than a 
straightforward choice about how to regulate 
nano  materials. 
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Manganese in Drinking Water and 
Intellectual Impairment in School-
Age Children
doi:10.1289/ehp.1103485
We read with interest the the article by 
Bouchard et al. (2011) on the effect of manga­
nese in drinking water on children’s IQ (intel­
ligence quotient). In this cross­sectional study, 
the authors examined IQ scores in relation 
to manganese exposure using four exposure 
metrics: a) concentration of manganese in tap 
water; b) concentration of manganese in hair 
samples; c) estimate of manganese intake from 
water consumption; and e) estimate of man­
ganese intake from diet consumption. 
One key finding from the study of 
Bouchard et al. (2011) is that a higher concen­
tration of manganese in tap water was signifi­
cantly associated with lower IQ. Compared 
with the other three exposure metrics used 
in the study, the concentration of manganese 
in water followed an almost perfect dose–
response relationship with children’s IQ, and 
it was shown to be a better predictor of lower 
IQ than the exposure metrics. We found this 
surprising for three reasons. First, in their 
analysis of the association between concen­
tration of manganese in tap water and IQ, 
Bouchard et al. included the entire study pop­
ulation (n = 362). We consider this inappro­
priate because 33% of the study participants 
(n = 121) did not drink tap water at home. 
Thus, these 121 children may have experi­
enced much lower exposure to manganese 
from tap water than the remaining children in 
the study. Second, if we consider the highest 
quintile of water­manganese concentration 
(median, 216 μg/L), the estimated manganese 
intake from water would be ≤ 0.43 mg/day for 
half of the children in this exposure group, 
assuming a daily water intake of 2 L. Even at 
this level, the intake of manganese from water 
was still far below the daily intake recom­
mended by the Institute of Medicine (2001): 
children 1–3 years of age (1.2 mg/day) and 
children 4–13 years of age (1.5–1.9 mg/day). 
Third, Bouchard et al. reported that the chil­
dren’s manganese intake from food was more 
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the amount ingested from water. This sug­
gests that if elevated manganese was causally 
related to lower IQ, the decrease in IQ was 
more likely due to the intake of manganese 
from both water and food sources than from 
water alone. While one can postulate differ­
ences in bio  availability between manganese 
in food and in water, these would need to 
be considerable to result in equal or greater 
uptake from water than from food.
The utility of hair as a biomarker for 
human exposure to manganese has yet 
not been established [Agency for Toxic 
Substances and Disease Registry (ATSDR) 
2001]. There is still a lack of standard pro­
cedure for collection of hair samples as well 
as insufficient evidence to demon  strate the 
effect of washing hair on analytical results 
(ATSDR 2001). Bouchard et al. (2011) 
excluded children with dyed hair, but it 
would be interesting to also distinguish chil­
dren with natural hair of different colors in 
the analysis, because levels of manganese in 
hair can vary by natural colors of hair.
Bouchard et al. (2011) generated an 
interesting hypothesis on neuro  toxicity of 
water manganese in children at a level that 
is currently considered to have no adverse 
effect (World Health Organization 2008), 
but we believe more studies will be needed to 
confirm their findings. To better characterize 
human exposure to manganese from water, 
it is important for future studies to quan­
tify bio  availability of manganese from water 
and from food sources. In addition, employ­
ing a prospective study design and control­
ling for all possible risk factors—including 
overall nutritional status—will be critical. 
Additionally, comparing hair with other bio­
markers of manganese exposure would be 
another area to explore for future studies.
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Manganese in Drinking Water: 
Bouchard Responds
doi:10.1289/ehp.1103485R
Chen and Copes raise some interesting issues 
regarding our article (Bouchard et al. 2011). 
In our study we investigated the change in IQ 
scores with respect to different exposure metrics 
for manganese. One of these metrics was home 
tap water manganese concentration, which was 
strongly associated with IQ deficits. Chen and 
Copes indicate that they consider it inappropri­
ate to include in this analysis children who did 
not drink tap water at home. Second, they note 
that even for children in the highest quintile 
of water manganese concentration, the intake 
of manganese from water ingestion is below 
the recom  mended dietary manganese intake 
(Institute of Medicine 2001). In response to 
their first point, it is important to consider that 
children who do not drink tap water are still 
exposed through the consumption of many 
foods and drinks prepared with tap water. In 
addition, and perhaps most important, chil­
dren might be exposed by inhalation of aero­
sols containing manganese when showering 
(Elsner and Spangler 2005). If this represents a 
significant source of exposure, which is unclear 
(Aschner 2006; Spangler and Elsner 2006), 
inhalation of aerosols could be responsible for 
inducing neuro  toxic effects. Indeed, inhaled 
manganese is delivered to the brain much more 
efficiently than ingested manganese, because it 
bypasses normal homeo  static mechanisms. 
Third, Chen and Copes make the point 
that because dietary intake of manganese 
intake is much higher than the amount 
ingested from water, the decrease in IQ is 
more likely due to intake of manganese from 
water and food sources collectively, rather 
than from water alone. The intake of man­
ganese from water consumption was indeed 
very small compared with dietary intake 
(medians, 8 and 2,335 μg/kg/month, respec­
tively), but we found no evidence that dietary 
manganese is related to cognitive abilities. As 
we reported in our article (Bouchard et al. 
2011), dietary manganese intake, assessed 
with a food frequency questionnaire, was not 
associated with IQ and did change the point 
estimates for water manganese concentration 
when included in the regression model.
We believe that the interpretations that 
assimilate manganese present in water to dietary 
manganese have had the effect of dismissing 
the potential risks of this source of exposure, 
thus slowing research into this question. Little 
is known about the absorption and retention 
of manganese from food versus water, or about 
inhalation of aerosols in showers. Although 
more research is necessary to understand the 
mechanisms by which manganese present in 
water might be neuro  toxic for children, we 
believe that our findings offer strong support for 
this hypothesis. Because manganese levels asso­
ciated with significant cognitive deficits in our 
study are common in ground  water, this prob­
lem could have a great public health impor­
tance. For instance, 11% of domestic wells have 
manganese concentrations > 140 μg/L in the 
United States (U.S. Geological Survey 2009). 
We agree that additional studies, ideally with a 
prospective design, are necessary. 
Finally, a valid biomarker of manga­
nese exposure would greatly advance our 
understanding of this metal’s toxic effects. 
We used hair, notably because its collection 
is much less invasive than blood sampling. 
Chen and Copes rightly point out the limi­
tations of hair as a biomarker, and research 
should explore new biomarkers. For instance, 
in a small study, saliva manganese levels 
were significantly higher in welders than in 
non  exposed subjects, and levels increased 
in welders with the more years of exposure 
(Wang et al. 2008). Also in that study, saliva 
manganese concentrations correlated with 
serum concentrations. Saliva is less invasive 
to collect than blood and less prone to exter­
nal contamination than hair; thus, it might 
be a useful biomarker. 
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Erratum :  
Assessing Long-Term Exposure in the California 
Teachers Study 
In an article published in Environmental Health Perspectives (Ostro 
et al. 2010), we analyzed the relation  ships of long­term exposure to fine 
particulate matter (≤ 2.5 μm in aerodynamic diameter; PM2.5) and its 
components with mortality in a cohort of > 100,000 active and retired 
female professionals participating in the California Teachers Study 
(CTS) cohort. We used a Cox proportional hazards model in which 
pollution exposure was measured as a continuous variable over the 
study period. Monthly average pollutant concentrations were obtained 
for each participant from measurements at the nearest PM2.5 moni­
tor within either 8 or 30 km of her geocoded resi  dential address. Each 
participant was assigned a single exposure value over the follow­up 
period, defined as the average pollutant concentration from the begin­
ning of the observation period (1 June 2002) to the woman’s date of 
death, loss to follow­up, or study termination (31 July 2007). Thus, 
exposure assignment was dependent on the duration of follow­up for 
each participant. 
In our article (Ostro et al. 2010), we reported associations of 
mortality from all causes, cardio  pulmonary disease, and ischemic 
heart disease (IHD) with PM2.5 mass and several of its components. 
However, the estimated hazard ratios (HRs) were generally higher 
than those reported from previous cohort studies (Dockery et al. 
1993; Eftim et al. 2008; Krewski et al. 2009; Laden et al. 2006; Pope 
et al. 1995). Part of this difference was likely due to the nature of the 
exposure assignment. Most previous cohort studies have assigned the 
same exposure period to all study subjects, regardless of when deaths 
occurred. Thus, estimated exposures for some study participants in 
several studies occurred after their deaths. In addition, exposures have 
usually been assigned to participants based on their residential address 
at enrollment only, without taking into account exposure changes 
that may have occurred throughout the study period or when par­
ticipants relocated. Finally, many previous studies measured exposure 
for only a subset of the years during which the cohort was followed. 
In an effort to reduce these aspects of exposure mis  classifi  ca  tion, we 
estimated exposures beginning prior to the cohort follow­up period, 
continuing to the end of the study or until the participant died or 
relocated out of state, incorporating updated exposure assignments 
when the subjects moved. 
Importantly, measured concentrations of several pollutants in 
California declined substantially from 2002 through 2007; annual 
average PM2.5, organic carbon (OC), and nitrates decreased by around 
30% each. These marked decreases in ambient PM2.5 concentrations 
resulted in lower average exposure estimates for cohort members who 
survived to the end of our study. Thus, the exposure assigned to a par­
ticipant who died at time t would tend to be greater for events occur­
ring early in the observation period, compared with the long­term 
average exposures of the participants who comprised the remainder of 
the risk set (i.e., those who were still part of the cohort study at time t 
and who subsequently experienced lower ambient pollution levels). 
We have reanalyzed the CTS data using time­dependent pollu­
tion metrics—in which the exposure estimates for everyone remaining 
alive in the risk set were recalculated at the time of each death—in 
order to compare their average exposures up to that time with that 
of the individual who had died. In this way, decedents and survi­
vors comprising the risk set had similar periods of pollution expo­
sure, without subsequent pollution trends influencing the surviving 
  women’s exposure estimates. 
As in our previous study (Ostro et al. 2010), we restricted the 
sample in this reanalysis to women living within 30 km of one of eight 
fixed­site monitors in the U.S. Environmental Protection Agency’s 
Speciation Trend Network (STN), resulting in a study population of 
almost 44,000 women. Residential addresses from study enrollment 
forward were geo  coded and linked with monthly pollutant averages at 
the nearest STN monitor to generate estimates of long­term exposure. 
We also used the same set of individual and ecological covariates in 
a Cox proportional hazards model as was used in the original study. 
Pollutants entered separately into the model included PM2.5 mass, 
elemental carbon (EC), OC, sulfate, nitrate, iron, potassium, silicon, 
and zinc. We used data on primary cause of death from August 2002 
through July 2007 to examine the relationships between pollutants and 
mortality from all causes and cardiopulmonary, pulmonary, and IHDs. 
The results are summarized in Erratum Table 1, scaled to the 
inter  quartile range (IQR) for each pollutant. HRs were significantly 
attenuated from our previous results. No associations were observed 
between all­cause mortality and PM2.5 or its components. For cardio­
pulmonary mortality, we observed significant associations for PM2.5 
mass, nitrate, sulfate, and silicon, with more modest associations for 
zinc. PM2.5 mass and all of its components were associated with mor­
tality from IHD, whereas none of the pollutants was associated with 
Erratum Table 1. Association between mortality outcomes and PM2.5 and its components using a 30-km buffer (n = 43,220).  
IQR 
(µg/m3)
All-cause  
(ICD-10 codes, all except S–Z) 
(n = 2,519)
Cardiopulmonary  
(ICD-10 codes, I00–I99, J00–J98)   
(n = 1,357)
Ischemic heart disease  
(ICD-10 codes, I20–I25) 
(n = 460)
Pulmonary  
(ICD-10, codes J00–J98) 
(n = 355)
Pollutant HR (95% CI) p-Value HR (95% CI) p-Value HR (95% CI) p-Value HR (95% CI) p-Value
PM2.5 6.1 1.03 (0.98–1.10) 0.26 1.11 (1.03–1.21) 0.01 1.31 (1.14–1.50) < 0.01 1.02 (0.87–1.19) 0.84
EC 0.65 1.02 (0.93–1.12) 0.65 1.07 (0.94–1.22) 0.28 1.46 (1.17–1.83) < 0.01 0.88 (0.68–1.15) 0.35
OC 0.84 1.00 (0.95–1.04) 0.91 1.04 (0.98–1.11) 0.19 1.13 (1.01–1.25) 0.03 0.95 (0.84–1.06) 0.35
Sulfate 2.2 1.06 (0.97–1.16) 0.18 1.14 (1.01–1.29) 0.03 1.48 (1.20–1.82)  < 0.01 1.04 (0.82–1.31) 0.77
Nitrate 3.2 1.03 (0.98–1.09) 0.27 1.11 (1.03–1.19) 0.01 1.27 (1.12–1.43) < 0.01 1.04 (0.90–1.20) 0.58
Iron 0.13 1.01 (0.93–1.11) 0.77 1.05 (0.93–1.19) 0.40 1.39 (1.13–1.72)  < 0.01 0.88 (0.69–1.13) 0.32
Potassium 0.07 1.01 (0.94–1.08) 0.85 1.06 (0.97–1.17) 0.22 1.27 (1.07–1.49)  < 0.01 0.90 (0.74–1.09) 0.27
Silicon 0.03 1.02 (0.99–1.06) 0.22 1.05 (1.00–1.10) 0.04 1.11 (1.02–1.20) 0.01 0.98 (0.89–1.08) 0.71
Zinc 0.01 1.03 (0.96–1.11) 0.45 1.09 (0.98–1.20)  0.10 1.33 (1.12–1.58) < 0.01 0.97 (0.79–1.18) 0.74
ICD-10, International Classification of Diseases, 10th Revision (World Health Organization 1993). Values shown are HRs [95% confidence intervals (CIs)] and p-values scaled to the IQR 
of each pollutant. All models are adjusted for smoking status, total pack-years, body mass index, marital status, alcohol consumption, second-hand smoke exposure at home, dietary 
fat, dietary fiber, dietary calories, physical activity, menopausal status, hormone replacement therapy use, family history of myocardial infarction or stroke, blood pressure medication 
and aspirin use, and neighborhood contextual variables (income, income inequality, education, population size, racial composition, unemployment). Environmental Health Perspectives  •  v o l u m e 119 | number 6 | June 2011  A 243
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pulmonary mortality. This Erratum Table 1 should replace Table 5 in 
our previous article (Ostro et al. 2010). 
Compared with our previous results (Ostro et al. 2010), these 
updated PM2.5 HRs are more consistent with several other pub­
lished estimates of mortality risks, which are scaled to an increment 
of 10 μg/m3 of long­term average PM2.5 and summarized in Erratum 
Table 2. For example, relative to our revised HR of 1.19 for cardio­
pulmonary disease, analogous HRs from previous studies include 1.09 
(95% CI, 1.03–1.16) from the American Cancer Society–Cancer 
Prevention II (ACS) cohort (cardio  pulmonary disease; Pope et al. 
2004), 1.28 (95% CI, 1.13–1.44) from the Harvard Six Cities 
study (cardiovascular disease; Laden et al. 2006), and 1.10 (95% 
CI, 0.94–1.28) from the Los Angeles subcohort of the ACS study 
(cardio  pulmonary disease; Jerrett et al. 2005). Much higher HRs were 
observed in the observational study of the Women’s Health Initiative 
cohort for cardio  vascular and IHD mortality (Miller et al. 2007). 
These revised results still support the existence of elevated risks of 
PM2.5­associated cardiopulmonary disease and IHD, and illustrate the 
importance of considering the impact of long­term pollution trends in 
modeling estimates of exposure. 
The authors declare they have no actual or potential competing financial 
interests.
Bart Ostro
California Office of Environmental Health Hazard Assessment
Oakland, California
E­mail: Bostro@Creal.cat
Peggy Reynolds
Debbie Goldberg
Andrew Hertz
Cancer Prevention Institute of California
Berkeley, California
Richard T. Burnett 
Hwashin Shin
Health Canada
Ottawa, Ontario, Canada
Edward Hughes
Edward Hughes Consulting
Ottawa, Ontario, Canada
Cynthia Garcia
California Air Resources Board Sacramento, California
Katherine D. Henderson 
Leslie Bernstein
City of Hope
Duarte, California
Michael Lipsett
California Department of Public Health
Richmond, California
RefeRences
Chen LH, Knutsen SF, Shavlik D, Beeson WL, Petersen F, Ghamsary M, et al. 2005. The associa-
tion between fatal coronary heart disease and ambient particulate air pollution: are females 
at greater risk? Environ Health Perspect 113:1723–1729.
Dockery DW, Pope CA III, Xu X, Spengler JD, Ware JH, Fay ME, et al. 1993. An association 
between air pollution and mortality in six U.S. cities. N Engl J Med 329:1753–1759.
Eftim SE, Samet JM, Janes H, McDermott A, Dominici F. 2008. Fine particulate matter and mor-
tality: a comparison of the Six Cities and American Cancer Society cohorts with a Medicare 
cohort. Epidemiology 19:209–216.
Jerrett M, Burnett RT, Ma R, Pope CA III, Krewski D, Newbold KB, et al. 2005. Spatial analysis of 
air pollution and mortality in Los Angeles. Epidemiology 16:727–736. 
Krewski D, Jerrett M, Burnett RT, Ma R, Hughes E, Shi Y, et al. 2009. Extended Follow-Up and 
Spatial Analysis of the American Cancer Society Study Linking Particulate Air Pollution 
Aand Mortality. HEI Research Report 140. Boston, MA:Health Effects Institute. 
Laden F, Schwartz J, Speizer FE, Dockery DW. 2006. Reduction in fine particulate air pollution 
and mortality: extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care 
Med 173:667–672.
Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, et al. 2007. Long-
term exposure to air pollution and incidence of cardiovascular events in women. N Engl J 
Med 356:447–458.
Ostro B, Lipsett M, Reynolds P, Goldberg D, Hertz A, Garcia C, et al. 2010. Long-term exposure 
to constituents of fine particulate air pollution and mortality: results from the California 
Teachers Study. Environ Health Perspect 118:363–369.
Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. 2002. Lung cancer, cardio-
pulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 
287:1132–1141.
Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, et al. 2004. Cardiovascular 
mortality and long-term exposure to particulate air pollution: epidemiological evidence of 
general pathophysiological pathways of disease. Circulation 109:71–77.
Pope CA III, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, et al. 1995. 
Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am 
J Respir Crit Care Med 151:669–674.
Puett RC, Hart JE, Yanosky JD, Paciorek C, Schwartz J, Suh H, et al. 2009. Chronic fine and 
coarse particulate exposure, mortality and coronary heart disease in the Nurses’ Health 
Study. Environ Health Perspect 117:1697–1701. 
World Health Organization 1993. International Classification of Diseases, 10th Revision. 
Geneva:World Health Organization. 
Erratum Table 2. Comparative HRs (95% CIs) associated with a 10-μg/m3 change in long-term exposure to PM2.5 in several cohort studies conducted in the United States.
Authors Exposure assessment All causes Cardiovascular Cardiopulmonary IHD
Ostro et al. (this report) From 1 year prior to follow-up until event (either 
death or end of study), time-dependent
1.06 (0.96–1.16)a 1.19 (1.05–1.36)a  1.55 (1.24–1.93)a
Ostro et al. (2010)  From 2 months prior to study through event month  1.84 (1.66–2.05)a 2.05 (1.80–2.36)a  2.89 (2.27–3.67)a
Pope et al. (2002, 2004) Four years prior to or at start of follow-up and 
2 years after end of follow-up 
1.06 (1.02–1.11) 1.12 (1.08–1.15) 1.09 (1.03–1.16)
Laden et al. (2006) Multiyear average concurrent with follow-up 1.16 (1.07–1.26) 1.28 (1.13–1.44)
Miller et al. (2007)  One year in middle of follow-up 1.76 (1.25–2.47)a 2.21 (1.17–4.16)a
Jerrett et al. (2005)  One year at end of follow-up  1.15 (1.03–1.29) 1.10 (0.94–1.28) 1.32 (1.05–1.66)
Eftim et al. (2008) Three-year average concurrent with follow-up 1.21 (1.15–1.27)
Chen et al. (2005)  Four-year moving average prior to event  1.42 (1.06–1.90)a
Puett et al (2009) One year prior to event 1.26 (1.02–1.54)a 2.02 (1.07–3.78)a
HRs are scaled to 10-μg/m3 change in PM2.5, in contrast to Table 1, in which HRs are scaled to the pollutant interquartile range. 
aWomen only. 